<!DOCTYPE html><!--  This site was created in Webflow. http://www.webflow.com  -->
<!--  Last Published: Thu Dec 31 2020 21:56:12 GMT+0000 (Coordinated Universal Time)  -->
<html data-wf-page="5f4418a0d939987bac9ad55e" data-wf-site="5c98f51c692912915cbca45d">
<head>
  <meta charset="utf-8">
  <title>Roche</title>
  <meta content="Roche" property="og:title">
  <meta content="Roche" property="twitter:title">
  <meta content="width=device-width, initial-scale=1" name="viewport">
  <meta content="UA-114905300-1" name="google-site-verification">
  <meta content="Webflow" name="generator">
  <link href="../css/normalize.css" rel="stylesheet" type="text/css">
  <link href="../css/webflow.css" rel="stylesheet" type="text/css">
  <link href="../css/yatinglu.webflow.css" rel="stylesheet" type="text/css">
  <script src="https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js" type="text/javascript"></script>
  <script type="text/javascript">WebFont.load({  google: {    families: ["Montserrat:100,100italic,200,200italic,300,300italic,400,400italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic","Lato:100,100italic,300,300italic,400,400italic,700,700italic,900,900italic","Open Sans:300,300italic,400,400italic,600,600italic,700,700italic,800,800italic","Raleway:regular,500,600,700,800","Poppins:200,300,regular,500,600,700","Sofia:regular"]  }});</script>
  <!-- [if lt IE 9]><script src="https://cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv.min.js" type="text/javascript"></script><![endif] -->
  <script type="text/javascript">!function(o,c){var n=c.documentElement,t=" w-mod-";n.className+=t+"js",("ontouchstart"in o||o.DocumentTouch&&c instanceof DocumentTouch)&&(n.className+=t+"touch")}(window,document);</script>
  <link href="../images/favicon.png" rel="shortcut icon" type="image/x-icon">
  <link href="../images/webclip.png" rel="apple-touch-icon">
  <script async="" src="https://www.googletagmanager.com/gtag/js?id=UA-151950983-1"></script>
  <script type="text/javascript">window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments);}gtag('js', new Date());gtag('config', 'UA-151950983-1', {'anonymize_ip': false});</script>
</head>
<body>
  <div class="landing-session roche">
    <div class="columns-3 w-row">
      <div class="column-7 w-col w-col-5">
        <h1 class="myheading1">Roche Smart Adhere App</h1>
        <p class="paragraph-3"><strong>Mobile App to Improve Patient&#x27;s Therapy Adherence.</strong><br><br><strong>Timeline: </strong>2017.08 - 2018.01<strong><br>Project type: </strong>App design for Roche clinical trial<strong><br>Collaboration: </strong>1 PM, 2 front-end dev, 2 researchers<strong><br>My roles: </strong>User research, UI/UX design, usability test<br>‍<br></p>
      </div>
      <div class="column-8 w-col w-col-7"><img src="../images/roche_3.png" loading="eager" width="800" sizes="(max-width: 479px) 81vw, (max-width: 767px) 35vw, 42vw" srcset="../images/roche_3-p-500.png 500w, ../images/roche_3-p-800.png 800w, ../images/roche_3-p-1080.png 1080w, ../images/roche_3.png 1200w" alt="" class="image-48"></div>
    </div>
  </div>
  <div class="section">
    <div class="bg-div roche"></div>
    <div class="container">
      <div class="project-details">
        <div class="text-paragraph">
          <div class="myheading3">WHAT IS SMART ADHERE APP</div>
          <p>The Roche Tech-Dev and Molecule teams seek opportunities to design and development of an application for IPF patients, in order to improve their adherence to the treatment. IPF is a chronic lung disease and the average life expectancy following diagnosis is about four years. Adherence to the treatment can play an important role to the patients&#x27; life quality and length. However current patients&#x27; adherence to the treatment is relatively low. That&#x27;s why we decided to create the Smart Adhere App, to help increase patients&#x27; adherence to their treatments.</p>
        </div>
        <div class="text-paragraph">
          <div class="myheading3">BEHAVIOR APPROACH</div>
          <div class="text-block-2">Patient persistent to Esbriet molecule has been shown to be influenced by the onset of side effects and the long term lack of perceived benefit. We collaborated with an agency focused on behaviour neuroscience to analyze the behavioural drivers behind patient persistence and assess the validity of digital tools as a solution for driving increased persistence.<br></div><img src="../images/appr.png" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/appr-p-500.png 500w, ../images/appr-p-800.png 800w, ../images/appr-p-1080.png 1080w, ../images/appr-p-1600.png 1600w, ../images/appr.png 1735w" alt="">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">USER RESEARCH</div>
          <div class="text-block-2">We analyzed the user research conducted by the molecule team as well as scientific literature related to IPF, patients and physicians as well as medication persistence to uncover key behaviour findings. We collected both quantitative and qualitative data. The data about topics discussed among patients at diagnosis n social medias and patient forums as the figure below shows. It demonstrates that patients are eager to know about more treatment options, to understand the disease and the prognosis of the disease. In the interviews, patients commented that they hoped that the diagnosis could be regarded earlier.<br></div><img src="../images/research.png" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/research-p-500.png 500w, ../images/research-p-800.png 800w, ../images/research-p-1080.png 1080w, ../images/research-p-1600.png 1600w, ../images/research-p-2000.png 2000w, ../images/research.png 2494w" alt="">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">Research analysis</div>
          <div class="text-block-2">We analyzed the user research conducted by the molecule team as well as scientific literature related to IPF, patients and physicians as well as medication persistence to uncover key behaviour findings. We collected the data about topics discussed among patients at diagnosis n social medias and patient forums as the figure below shows. It demonstrates that patients are eager to know about more treatment options, to understand the disease and the prognosis of the disease.<br></div><img src="../images/analysis.png" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/analysis-p-500.png 500w, ../images/analysis-p-800.png 800w, ../images/analysis-p-1080.png 1080w, ../images/analysis-p-1600.png 1600w, ../images/analysis-p-2000.png 2000w, ../images/analysis.png 2436w" alt="">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">DIVERGENT: IDEATION</div><img src="../images/steps.png" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/steps-p-500.png 500w, ../images/steps-p-800.png 800w, ../images/steps-p-1080.png 1080w, ../images/steps-p-1600.png 1600w, ../images/steps.png 1798w" alt="">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">POSSIBLE FEATURES</div><img src="../images/Screenshot-2019-12-17-at-18.30.36.png" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/Screenshot-2019-12-17-at-18.30.36-p-500.png 500w, ../images/Screenshot-2019-12-17-at-18.30.36-p-800.png 800w, ../images/Screenshot-2019-12-17-at-18.30.36-p-1080.png 1080w, ../images/Screenshot-2019-12-17-at-18.30.36.png 1590w" alt="">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">CONVERGENT:  USER JOURNEY</div>
          <div class="text-block-2">Journey 1: Working through the &quot;Understanding IPF &amp; Esbriet&quot; course to build user&#x27;s knowledge<br></div><img src="../images/journey1.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/journey1-p-500.png 500w, ../images/journey1-p-800.png 800w, ../images/journey1-p-1080.png 1080w, ../images/journey1-p-1600.png 1600w, ../images/journey1-p-2000.png 2000w, ../images/journey1-p-2600.png 2600w, ../images/journey1-p-3200.png 3200w, ../images/journey1.png 6216w" alt="" class="image-22">
          <div class="text-block-2">Journey 2: Viewing and inputting information in &quot;My Treatment&quot; and &quot;My Dose&quot;, and then being prompted to start a &quot;Medication Journal&quot; to reflect on the start of treatment.<br></div><img src="../images/journey2.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/journey2-p-500.png 500w, ../images/journey2-p-800.png 800w, ../images/journey2-p-1080.png 1080w, ../images/journey2-p-1600.png 1600w, ../images/journey2-p-2000.png 2000w, ../images/journey2-p-2600.png 2600w, ../images/journey2-p-3200.png 3200w, ../images/journey2.png 6216w" alt="" class="image-22">
          <div class="text-block-2">Journey 3: Viewing a personalised daily feed in &quot;My News&quot; to make use of the app habit forming, and provide the user with the information they need to stay persistent.<br></div><img src="../images/journey3.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/journey3-p-500.png 500w, ../images/journey3-p-800.png 800w, ../images/journey3-p-1080.png 1080w, ../images/journey3-p-1600.png 1600w, ../images/journey3-p-2000.png 2000w, ../images/journey3-p-2600.png 2600w, ../images/journey3-p-3200.png 3200w, ../images/journey3.png 5169w" alt="" class="image-22">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">Prototyping</div>
          <div class="div-block-58"><img src="../images/Esbriet_Passport_app_updated.gif" width="849" alt="" class="image-22 prototype"></div>
        </div>
        <div class="text-paragraph"></div>
        <div class="text-paragraph">
          <div class="myheading3">Usability tEST</div>
          <div class="text-block-2">To evaluate and improve the MVP of our application, a formative human factor study was designed and conducted to evaluate the usability.​The study design was shown as the diagram below. In total 14 (8 women, 6 men) internal Roche colleagues participated in the tests. Each participant was asked to perform the tasks as shown below. It would be marked completion if the participant successfully did it without assistance.<br></div><img src="../images/study_components.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/study_components-p-500.png 500w, ../images/study_components-p-800.png 800w, ../images/study_components-p-1080.png 1080w, ../images/study_components-p-1600.png 1600w, ../images/study_components-p-2000.png 2000w, ../images/study_components.png 2274w" alt="" class="image-22"><img src="../images/specific_task_completion.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/specific_task_completion-p-500.png 500w, ../images/specific_task_completion-p-800.png 800w, ../images/specific_task_completion-p-1080.png 1080w, ../images/specific_task_completion-p-1600.png 1600w, ../images/specific_task_completion-p-2000.png 2000w, ../images/specific_task_completion.png 2082w" alt="" class="image-22">
          <div class="text-block-2">The usability test result is shown as below. Generally, the SEQ scores are quite good, and the completion rates are satisfying for most of the features.<br></div><img src="../images/task_result.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/task_result-p-500.png 500w, ../images/task_result-p-800.png 800w, ../images/task_result-p-1080.png 1080w, ../images/task_result-p-1600.png 1600w, ../images/task_result-p-2000.png 2000w, ../images/task_result.png 2276w" alt="" class="image-22">
        </div>
        <div class="text-paragraph">
          <div class="myheading3">Key feature redesign</div>
          <div class="text-block-2">After the usability test, we identified some problematic features and redesigned the UI accordingly.<br></div><img src="../images/smart_pilot.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/smart_pilot-p-500.png 500w, ../images/smart_pilot-p-800.png 800w, ../images/smart_pilot-p-1080.png 1080w, ../images/smart_pilot-p-1600.png 1600w, ../images/smart_pilot.png 2000w" alt="" class="image-22"><img src="../images/iteration2_1.png" width="849" sizes="(max-width: 479px) 86vw, (max-width: 767px) 77vw, 80vw" srcset="../images/iteration2_1-p-500.png 500w, ../images/iteration2_1-p-800.png 800w, ../images/iteration2_1-p-1080.png 1080w, ../images/iteration2_1-p-1600.png 1600w, ../images/iteration2_1-p-2000.png 2000w, ../images/iteration2_1.png 2560w" alt="" class="image-22">
        </div>
        <div class="text-paragraph"></div>
      </div>
    </div>
    <div class="nav-bar">
      <div class="div-block-14">
        <a href="../index.html" class="w-inline-block">
          <div class="div-block-13">
            <div class="text-block-3">Y</div>
          </div>
        </a>
      </div>
      <div class="div-block-11">
        <a href="../index.html" class="link">PORTFOLIO</a>
        <a href="../about.html" class="link">ABOUT</a>
      </div>
    </div>
  </div>
  <div class="next-page roche">
    <a href="../work/corporate-web.html" class="button-2 w-button"><strong>← </strong>Previous Project</a>
    <a href="../work/microsoft.html" class="button-2 w-button">Next Project →</a>
  </div>
  <div class="footer-wrap">
    <div class="div-block-60">
      <h6 class="heading-13">© Yating Lu 2020</h6>
    </div>
    <div class="div-block-59">
      <a href="mailto:yatinglu@outlook.com" class="link-block-2 w-inline-block"><img src="../images/email-1.svg" alt="" class="image-37"></a>
      <a href="https://www.linkedin.com/in/yatinglu900/" target="_blank" class="link-block-2 w-inline-block"><img src="../images/linkedin0.svg" alt="" class="image-38"></a>
      <a href="https://medium.com/@yatinglu" target="_blank" class="link-block-2 w-inline-block"><img src="../images/medium-circle-fill.svg" alt="" class="image-37 s"></a>
      <a href="https://dribbble.com/Yating900" target="_blank" class="link-block-2 w-inline-block"><img src="../images/dribbble_1.svg" alt="" class="image-34 ss"></a>
    </div>
  </div>
  <script src="https://d3e54v103j8qbb.cloudfront.net/js/jquery-3.5.1.min.dc5e7f18c8.js?site=5c98f51c692912915cbca45d" type="text/javascript" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script>
  <script src="../js/webflow.js" type="text/javascript"></script>
  <!-- [if lte IE 9]><script src="https://cdnjs.cloudflare.com/ajax/libs/placeholders/3.0.2/placeholders.min.js"></script><![endif] -->
</body>
</html>